Humacyte, Inc.

NasdaqGS:HUMA Stock Report

Market Cap: US$206.5m

Humacyte Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HUMA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,389,2851.53%
Individual Insiders9,455,1594.26%
Public Companies18,312,7358.25%
Institutions61,945,10127.9%
General Public128,916,82858.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 43.1%.

Top Shareholders

Top 25 shareholders own 38.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.25%
Fresenius Medical Care AG
18,312,735US$17.0m0%no data
5.55%
BlackRock, Inc.
12,316,955US$11.5m8.57%no data
4.03%
Gavril Yushvaev
8,942,078US$8.3m0%no data
3.79%
The Vanguard Group, Inc.
8,416,971US$7.8m11.9%no data
2.58%
Antipodes Partners Ltd.
5,723,750US$5.3m49,000%0.09%
1.68%
Geode Capital Management, LLC
3,720,436US$3.5m20.2%no data
1.34%
UBS Asset Management AG
2,978,610US$2.8m48.8%no data
1.28%
State Street Global Advisors, Inc.
2,837,276US$2.6m17.8%no data
1.19%
Millennium Management LLC
2,631,990US$2.4m130%no data
1.13%
Morgan Stanley
2,497,976US$2.3m19.8%no data
1.01%
Ayabudge LLC
2,241,045US$2.1m0%no data
0.9%
Woodline Partners LP
2,002,073US$1.9m0%0.01%
0.71%
Citadel Advisors LLC
1,566,431US$1.5m75.4%no data
0.67%
Two Sigma Investments, LP
1,491,467US$1.4m9.14%no data
0.56%
Charles Schwab Investment Management, Inc.
1,239,477US$1.2m0%no data
0.52%
The Niklason Living Trust
1,148,240US$1.1m0%no data
0.52%
Northern Trust Global Investments
1,146,910US$1.1m11.2%no data
0.45%
Susquehanna International Group, LLP
1,009,670US$939.1k-11.7%no data
0.38%
LPL Financial LLC
837,661US$779.1k5.93%no data
0.38%
Private Advisor Group, LLC
832,799US$774.6k48.3%no data
0.33%
Barclays PLC
729,387US$678.4k299%no data
0.32%
Medical Strategy GmbH
718,447US$668.2k-15.1%0.05%
0.29%
XTX Markets Limited
650,858US$605.4k236%0.02%
0.23%
Lion Point Capital, LP
500,000US$465.1k499%1.75%
0.22%
Marshall Wace LLP
488,369US$454.2k-40.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/17 13:55
End of Day Share Price 2026/05/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Humacyte, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew MiksicBarclays
Bruce JacksonBenchmark Company
Michael GormanBTIG